Ado-trastuzumab emtansine Intravenous and Dolasetron Injection
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Dolasetron Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: dolasetron
Brand name: Anzemet
Synonyms: Dolasetron
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Dolasetron Mesylate
- Ado-trastuzumab emtansine Intravenous-Dolasetron Oral, Intravenous
- Ado-trastuzumab emtansine Intravenous-Dolasetron Tablets
- Ado-trastuzumab emtansine Intravenous-Dolgic LQ Oral
- Ado-trastuzumab emtansine Intravenous-Dolgic Plus
- Ado-trastuzumab emtansine Intravenous-Dolobid
- Dolasetron Injection-Adox Pak 2/100
- Dolasetron Injection-Adoxa
- Dolasetron Injection-Adoxa CK
- Dolasetron Injection-Adoxa Pak
- Dolasetron Injection-Adoxa Pak 1/100
- Dolasetron Injection-Adoxa Pak 1/150